Atlas Trials

Kadmon, a Sanofi Company

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kadmon, a Sanofi Company

RecordFirmDate
Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (NCT05567406)Kadmon, a Sanofi Company2025-06-16
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors (NCT04242147)Kadmon, a Sanofi Company2023-03-06
A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male Subjects (NCT05806567)Kadmon, a Sanofi Company2022-07-27
Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213 (NCT05305989)Kadmon, a Sanofi Company2022-02-23
Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (NCT04680975)Kadmon, a Sanofi Company2021-03-03
KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment (NCT04166942)Kadmon, a Sanofi Company2019-12-11
KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis (NCT03919799)Kadmon, a Sanofi Company2019-06-26
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy (NCT03640481)Kadmon, a Sanofi Company2018-10-11
Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD (NCT03203642)Kadmon, a Sanofi Company2017-10-12

Track Kadmon, a Sanofi Company automatically

Every clearance here is in the API, with alerts when new ones post.